文献速递肺外科

Ⅰ期非小细胞肺癌肺叶切除术并发症的相对增量成本

Relative incremental costs of complications of lobectomy for stage I non-small cell lung cancer.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-11-20

该研究纳入2008至2014年间接受开放或电视辅助胸腔镜手术(VATS)肺叶切除术的Ⅰ期非小细胞肺癌(NSCLC)患者488例,查询90天术后并发症并链接医院成本数据,用线性回归评估特定并发症对直接住院成本的影响。结果显示34%患者发生至少1种并发症、17%发生至少1种严重并发症;轻微并发症使肺叶切除术相对成本增加29%(95%CI 23%-34%,P<.001),严重并发症增加57%(95%CI 53%-62%,P<.001),严重肺部并发症增加111%(95%CI 96%-126%,P<.001)。作者结论认为并发症显著贡献于90天直接住院总成本,严重肺部并发症、房性心律失常、肺炎和迁延性漏气是成本削减的4个高产出目标。

要点

  • 488例Ⅰ期NSCLC肺叶切除术患者中,34%发生至少1种并发症,17%发生至少1种严重并发症。
  • 轻微并发症使相对成本增加29%(95%CI 23%-34%,P<.001),严重并发症增加57%(95%CI 53%-62%,P<.001)。
  • 严重肺部并发症使成本增加111%(95%CI 96%-126%,P<.001),是90天成本增加的最强预测因素。

核心结论

  • 轻微和严重并发症均显著贡献于Ⅰ期NSCLC肺叶切除术的90天直接住院总成本。
  • 分析90天术后结局能更准确地捕捉成本。
  • 严重肺部并发症、房性心律失常、肺炎和迁延性漏气是成本削减的4个高产出目标。
  • 在改善患者结局的同时控制医疗支出的努力,或许最应聚焦于降低相对增量成本最大的并发症。

研究设计与样本

  • 研究纳入2008至2014年间接受开放或VATS肺叶切除术的Ⅰ期NSCLC患者,共488例。
  • 查询患者登记库中90天术后 interval 内记录的所有并发症。
  • 将每位患者的医院成本数据与临床数据链接。
  • 采用线性回归评估特定并发症对直接住院成本的影响。

主要发现

  • 488例患者中34%发生至少1种并发症,17%发生至少1种严重并发症。
  • 发生并发症的患者中,最常见者为房性心律失常(13%)、迁延性漏气(8.6%)、肺不张(6.4%)和输血需求(4.5%)。
  • 与无并发症肺叶切除术相比,轻微并发症使相对成本增加29%(95%CI 23%-34%,P<.001)。
  • 严重并发症使成本增加57%(95%CI 53%-62%,P<.001)。
  • 严重肺部并发症使90天成本增加111%(95%CI 96%-126%,P<.001);迁延性漏气使相对平均成本增加22%(95%CI 10%-33%,P<.001),肺炎增加96%(95%CI 75%-117%,P<.001)。

临床怎么用

  • 原文结论指出,严重肺部并发症、房性心律失常、肺炎和迁延性漏气是成本削减的4个高产出目标。
  • 原文结论认为,在改善患者结局的同时控制医疗支出的努力,或许最应聚焦于降低相对增量成本最大的并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the relative incremental cost of complications after lobectomy for stage I non-small cell lung cancer (NSCLC). METHODS: Patients treated with open or video-assisted thoracoscopic surgery (VATS) lobectomy for stage I NSCLC between 2008 and 2014 were selected. A patient registry was queried for all complications recorded during a 90-day postoperative interval. Hospital cost data for each patient was concatenated with clinical data. Linear regression was used to assess the impact on direct hospital costs of specific complications. RESULTS: Among the 488 patients included in this study, 34% experienced ≥1 complication and 17% experienced ≥1 major complication. In patients experiencing complications, atrial arrhythmia (13%), prolonged air leak (8.6%), atelectasis (6.4%), and transfusion requirement (4.5%) were most common. Minor complications increased the relative cost of lobectomy by 29% (95% confidence interval [CI], 23%-34%; P < .001) compared to the cost of an uncomplicated lobectomy. Major complications increased costs by 57% (95% CI, 53%-62%; P < .001). The greatest predictor of increased 90-day cost was major pulmonary complications, which increased cost by 111% (95% CI, 96%-126%; P < .001). Prolonged air leak increased relative mean cost by 22% (95% CI, 10%-33%; P < .001) and pneumonia by 96% (95% CI, 75%-117%; P < .001). CONCLUSIONS: Complications, both major and minor, contribute significantly to the total 90-day direct hospital cost of lobectomy for stage I NSCLC. Analysis of 90-day postoperative outcomes more accurately captures costs. Major pulmonary complications, atrial arrhythmia, pneumonia, and prolonged air leak represent 4 high-yield targets for cost reduction. Efforts to control health care spending while improving patient outcomes might optimally focus on reducing complications that incur the greatest relative incremental cost.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Geller AD, Zheng H, Mathisen DJ, et al. Relative incremental costs of complications of lobectomy for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2017. PMID: 29254638. doi:10.1016/j.jtcvs.2017.11.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。